Skip to the page

Data / Drug companies / Medical Purchasing Solutions, LLC

Medical Purchasing Solutions, LLC: 269 products in the FDA NDC directory, labeler code 71872

Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).

Medical Purchasing Solutions, LLC (labeler code 71872) lists 269 products in the FDA National Drug Code Directory, covering 70 finished drugs by generic name. By type: 269 prescription drugs. Its main marketing category is generic drugs (ANDA). The newest product started marketing on July 28, 2026.

The request: Watch Medical Purchasing Solutions, LLC (FDA labeler code 71872): each new product listing and each discontinued product. $10 of work on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

Labeler code
71872
Products in commercial distribution
269
Packages
268
Finished drugs by generic name
70
Prescription products
269
Over the counter products
0
Controlled substance products
Schedule III 2, Schedule IV 2
Started marketing in the last 12 months
1
Earliest marketing start
April 2, 1959
openFDA record search
api.fda.gov

Products by marketing category

Share of the company's products in commercial distribution.

Marketing categoryProductsShare
Generic drugs (ANDA)22382.9%
New drug applications (NDA)4115.2%
Other unapproved drugs31.1%
Authorized generics (NDA)20.7%

Products by type

TypeProductsShare
Prescription drugs269100%

Drugs it lists

Finished drugs by generic name, with how many companies list each.

DrugProductsCompanies listing it
Lidocaine hydrochloride20134
Glycopyrrolate1564
Dexamethasone sodium phosphate1325
Epinephrine1232
Furosemide963
Atropine sulfate824
Naloxone hydrochloride840
Rocuronium bromide825
Clindamycin phosphate831
Verapamil hydrochloride746
Phenylephrine hydrochloride777
Ephedrine sulfate626
Nitroglycerin640
Succinylcholine chloride627
Ketorolac tromethamine669
Sodium bicarbonate651
Amiodarone hydrochloride535
Flumazenil58
Dextrose monohydrate512
Hydralazine hydrochloride447
Heparin sodium423
Vasopressin415
Neostigmine methylsulfate424
Diphenhydramine hydrochloride4127
Metoprolol tartrate446
Ondansetron452
Gentamicin sulfate320
Ampicillin sodium311
Famotidine3138
Methylprednisolone sodium succinate314
Dexmedetomidine hydrochloride321
Nalbuphine hydrochloride35
Bupivacaine hydrochloride323
Magnesium sulfate heptahydrate320
Ampicillin310
Diltiazem hydrochloride255
Water240
Esmolol hydrochloride212
Diazepam251
Dopamine hydrochloride210
Procainamide hydrochloride210
Sugammadex222
Propranolol hydrochloride251
Cosyntropin24
Calcium chloride214
Adenosine215
Iohexol23
Sodium chloride271
Cefazolin211
Aminophylline25
Metoclopramide230
Promethazine hydrochloride249
Ketamine hydrochloride211
Aminocaproic acid223
Succinylcholine12
Albuterol sulfate146
Ampicillin sodium and sulbactam sodium17
Calcium gluconate114
Atropine sulfate monohydrate12
Calcium chloride injection13
Nalxone hydrochloride13
Dexmedetomidine hcl12
Metoclopramide hydrochloride113
Neostigmine12
Metoroprolol tartrate13
Terbutaline sulfate110
Dexmedetomidine111
Digoxin133
Phenytoin sodium124
Rocuronium13

Dosage forms

Dosage formProductsShare
Injection, solution14152.4%
Injection9635.7%
Injection, powder, for solution124.5%
Solution83%
Tablet62.2%
Injection, solution, concentrate31.1%
Injection, powder, lyophilized, for solution20.7%
Spray10.4%

Pharmacologic classes

FDA established pharmacologic classes of its products.

Newest products

By marketing start date.

ProductProduct NDCDosage formMarketing categoryMarketing start
Sugammadex71872-7382Injection, solutionGeneric drugs (ANDA)July 28, 2026
Sodium bicarbonate71872-7376Injection, solutionGeneric drugs (ANDA)August 7, 2025
Lidocaine hydrochloride71872-7362Injection, solutionGeneric drugs (ANDA)July 1, 2025
Diphenhydramine Hydrochloride71872-7373InjectionGeneric drugs (ANDA)June 30, 2025
Magnesium Sulfate71872-7381Injection, solutionGeneric drugs (ANDA)May 28, 2025
Procainamide Hydrochloride71872-7353Injection, solutionGeneric drugs (ANDA)January 15, 2025
Famotidine71872-7366Injection, solutionGeneric drugs (ANDA)December 15, 2024
Atropine Sulfate71872-7355SolutionGeneric drugs (ANDA)December 9, 2024
Dexamethasone Sodium Phosphate71872-7347Injection, solutionGeneric drugs (ANDA)December 1, 2024
Amiodarone Hydrochloride71872-7354Injection, solutionGeneric drugs (ANDA)October 31, 2024
Ketorolac tromethamine71872-7363Injection, solutionGeneric drugs (ANDA)October 4, 2024
Rocuronium bromide71872-7372Injection, solutionGeneric drugs (ANDA)October 3, 2024
Nalbuphine hydrochloride71872-7331InjectionGeneric drugs (ANDA)September 26, 2024
Nitroglycerin71872-7383TabletGeneric drugs (ANDA)September 1, 2024
Furosemide71872-7350InjectionNew drug applications (NDA)August 19, 2024
Neffy71872-7330SprayNew drug applications (NDA)August 9, 2024
Atropine Sulfate71872-7341SolutionGeneric drugs (ANDA)July 4, 2024
Atropine Sulfate71872-7340SolutionGeneric drugs (ANDA)July 4, 2024
Diltiazem Hydrochloride71872-7345Injection, solutionGeneric drugs (ANDA)June 1, 2024
Vasopressin71872-7334InjectionGeneric drugs (ANDA)May 9, 2024
Heparin Sodium71872-7352InjectionGeneric drugs (ANDA)April 1, 2024
Heparin Sodium71872-7351InjectionGeneric drugs (ANDA)April 1, 2024
Sodium bicarbonate71872-7371Injection, solutionGeneric drugs (ANDA)March 15, 2024
Epinephrine71872-7360InjectionNew drug applications (NDA)March 7, 2024
Nitroglycerin71872-7338TabletGeneric drugs (ANDA)December 5, 2023

CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.